Skip to main content
. 2020 Nov 1;27(11):1183–1207. doi: 10.5551/jat.54353

Supplemental Table 10. Distribution of VLDL particle sizes (absolute values).

Baseline Week 12
Cholesterol particle size of VLDL, nm
    Placebo 42.79 (41.64, 44.12) 42.45 (41.42, 44.09)
    Evolocumab 42.64 (41.63, 43.81) 42.87 (41.65, 44.37)

Change from baseline, %
    Placebo −0.29 (−2.66, 2.20)
    Evolocumab 0.34 (−1.95, 3.58)

Abbreviation: VLDL, very low-density lipoprotein. Data are expressed as median (1st quartile, 3rd quartile).